Four-week nicotine skin patch treatment effects on cognitive performance in Alzheimer's disease

Psychopharmacology

Volumn 143, Issue 2, 1999, Pages 158-165

  White, Heidi K ^b   Levin, Edward D ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b DURHAM VA MEDICAL CENTER   (United States)

Author keywords

Alzheimer's disease; Attention; Nicotine; Nicotine skin patches

Indexed keywords

NICOTINE;

ADULT; AGED; AGITATION; ALZHEIMER DISEASE; ANOREXIA; ANXIETY; ARTICLE; ATTENTION; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG SCREENING; FEMALE; HEADACHE; HUMAN; MALE; NAUSEA; PRIORITY JOURNAL; TRANSDERMAL DRUG ADMINISTRATION; VERTIGO; VISUAL IMPAIRMENT;

ADMINISTRATION, CUTANEOUS; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ATTENTION; COGNITION; FEMALE; HUMANS; MALE; MEMORY; MIDDLE AGED; NICOTINE; NICOTINIC AGONISTS; PSYCHOMOTOR PERFORMANCE; TREATMENT OUTCOME;

EID: 0032893921     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130050931     Document Type: Article

References (46)

1. Akaike A, Tamura Y, Yokota T, Shimohama S, Kimura J (1994) Nicotine-induced protection of cultured cortical neurons against N-methyl-D-aspartate receptor-mediated glutamate cytotoxicity. Brain Res 644:181-187
2. Brenner DE, Kukull WA, Vanbelle G, Bowen JD, Mccormick WC, Teri L, Larson EB (1993) Relationship between cigarette smoking and Alzheimer's disease in a population-based case-control study. Neurology 43:293-300
3. Brink TL, Yesavage JA, Lum O, Heersema PH, Adey M, Rose TL (1982) Screening tests for geriatric depression. Clin Gerontol 1:37-43
4. Conners CK (1994) The Continuous Performance Test (CPT): Use as a diagnostic tool and measure of treatment outcome. Annual Convention of the American Psychological Association, Los Angeles, Calif.
5. Conners CK (1995) The continuous performance test. Multi-Health Systems, Toronto
6. Conners CK, Levin ED, Sparrow E, Hinton S, Ernhardt D, Meck WH, Rose JE, March J (1996) Nicotine and attention in adult ADHD. Psychopharmacol Bull 32:67-73
7. DeJong R, Osterlund OW, Roy GW (1989) Measurement of quality of life changes in patients with Alzheimer's disease. Clin Ther 11:545-553
8. Guy W (1976) Clinical global impressions. In : (ed) ECDEU assessment manual for psychopharmacology, revised edition. Department of Health, Education, and Welfare, Rockville, Md., pp 218-222
9. Henningfield JE, Obarzanek E, Benowitz NL, Hall SM, Klesges RC, Leischow S, Levin ED, Perkins KA, Spring B, Stitzer M, Ward MM, Wood P, Woods MN, Isbell T, Klem ML (1992) Task force 2 : methods and assessment, strategies for research. Health Psychol 11:10-16
10. Hughes CP, L. B, Danzinger WL, Coben LA, Martin RL (1982) A new clinical scale for the staging of dementia. Br J Psychiatry 140:566-572
11. Jones GMM, Sahakian BJ, Levy R, Warburton DM, Gray JA (1992) Effects of acute subcutaneous nicotine on attention, information processing and short-term memory in Alzheimer's disease. Psychopharmacology 108:485-494
12. Joseph AM, Norman SM, Ferry LH, Prochazka AV, Westman EC, Steele BG, Sherman SE, Cleveland M, Antonnucio DO, Hartman N, McGovern PG (1996) The safety of transdermal nicotine as an aid to smoking cessation in patients with cardiac disease. N Engl J Med 335:1792-1798
13. Katayama S, Hirata K, Tanaka H, Yamazaki K, Fujikane M, Ichimaru Y (1995) Efficacy of transdermal nicotine in dementia: a study using event-related potentials and a middle latency response. In : Domino EF (ed) Brain imaging of nicotine and tobacco Smoking. Npp Books, Ann Arbor, Mich., pp 289-302
14. Lawrence AD, Sahakian BJ (1995) Alzheimer's disease, attention, and the cholinergic system. Alz Dis Assoc Disord 9:43-49
15. Lawrence AD, Sahakian BJ (1998) The cognitive psychopharmacology of Alzheimer's disease. Neurochem Res 23:787-794
16. Lawton MP, Brody EM (1969) Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist 9:176-186
17. Levin ED, Simon BB (1998) Nicotinic acetylcholine involvement in cognitive function in animals. Psychopharmacology 138: 217-230
18. Levin ED, Torry D (1996) Acute and chronic nicotine effects on working memory in aged rats. Psychopharmacology 123:88-97
19. Levin E, Wilson W, Rose J, McEvoy J (1996a) Nicotine-haloperidol interactions and cognitive performance in schizophrenics. Neuropsychopharmacology 15:429-436
20. Levin ED, Conners CK, Sparrow E, Hinton SC, Erhardt D, Meck WH, Rose JE, March J (1996b) Nicotine effects on adults with attention-deficit hyperactivity disorder. Psychopharmacology 123:55-63
21. Levin ED, Conners CK, Silva D, Hinton SC, Meck WH, March J, Rose JE (1998) Transdermal nicotine effects on attention. Psychopharmacology 140:135-141
22. Marks MJ, Stitzel JA, Collins AC (1985) Time course study of the effects of chronic nicotine infusion on drug response and brain receptors. J Pharmacol Exp Ther 235:619-628
23. McGehee DS, Heath MJS, Gelber S, Devay P, Role LW (1995) Nicotine enhancement of fast excitatory synaptic transmission in CNS by presynaptic receptors. Science 269:1692-1696
24. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 34:939-944
25. Newhouse PA, Sunderland T, Tariot PN, Blumhardt CL, Weingartner H, Mellow A, Murphy DL (1988) Intravenous nicotine in Alzheimer's disease: a pilot study. Psychopharmacology 95:171-175
26. Newhouse PA, Potter A, Levin ED (1997) Nicotinic systems and Alzheimer's disease: implications for therapeutics. Drugs Aging 11:206-228
27. Nordberg A (1993) Clinical studies in Alzheimer patients with positron emission tomography. Behav Brain Res 57:215-224
28. Nordberg A (1995) Imaging of nicotinic receptors in human brain. In : Domino EF (ed) Brain imaging of nicotine and tobacco smoking. Npp Books, Ann Arbor, Mich., pp 45-57
29. Perry E (1995) Cholinergic signaling in Alzheimer disease: therapeutic strategies. Alz Dis Assoc Disord 9:1-2
30. Provost SC, Woodward R (1991) Effects of nicotine gum on repeated administration of the Stroop test. Psychopharmacology 104:536-540
31. Reeves D, Bleiberg J, Spector J (1993a) Validation of the ANAM battery in multi-center head injury rehabilitation studies. Arch Clin Neuropsychol 8:356
32. Reeves D, Kane R, Winter K, Raynsford K, Pancella T (1993b) Automated Neuropsychological Assessment Metrics (ANAM): test administrator's guide version 1.0. Missouri Institute of Mental Health, St Louis
33. Rosen WG, Mohs RC, Davis KL (1984) A new rating scale for Alzheimer's disease. Am J Psychiatry 141:1356-1364
34. Russell EW (1975) A multiple scoring method for the assessment of complex memory functions. J Consult Clin Psychol 43:800-809
35. Rusted J, Graupner L, Oconnell N, Nicholls C (1994) Does nicotine improve cognitive function? Psychopharmacology 115: 547-549
36. Sahakian BJ, Jones GMM (1991) The effects of nicotine on attention, information processing, and working memory in patients with dementia of the Alzheimer type. In: Adlkofer F, Thruau K (eds) Effects of nicotine on biological systems. Birkhauser, Basel, pp 623-230
37. Sahakian B, Jones G, Levy R, Gray J, Warburton D (1989) The effects of nicotine on attention, information processing, and short-term memory in patients with dementia of Alzheimer type. Br J Psychiatry 154:797-800
38. Shimohama S, Taniguchi T, Fujiwara M, Kameyama M (1986) Changes in nicotinic and muscarinic receptors in Alzheimer-type dementia. J Neurochem 46:288-293
39. Snaedal J, Johannesson T, Jonsson JE, Gylfadottir G (1996) The effects of nicotine in dermal plaster on cognitive functions in patients with Alzheimer's disease. Dementia 7:47-52
40. Standaert DG, Young AB (1996) Treatment of central nervous system degenerative disorders. In: Hardman JG, Gilman AG, Limbard LL (eds) Goodman & Gilman's the pharmacological basis of therapeutics. McGraw-Hill, New York, pp 503-519
41. Wang PN, Wang SJ, Hong CJ, Liu TT, Fuh JL, Chi CW, Liu CY, Liu HC (1997) Risk factors for Alzheimer's disease: a case-control study. Neuroepidemiology 16:234-240
42. Warburton DM, Arnall C (1994) Improvements in performance without nicotine withdrawal. Psychopharmacology 15:539-542
43. Wesnes K, Revell A (1984) The separate and combined effects of scopolamine and nicotine on human information processing. Psychopharmacology 84:5-11
44. White H, Pieper C, Schmader K, Fillenbaum G (1996) Weight change in Alzheimer's disease. J Am Geriatr Soc 44:265-272
45. Wilson AL, Langley LK, Monley J, Bauer T, Rottunda S, McFalls E, Kovera C, McCarten JR (1995) Nicotine patches in Alzheimer's disease: pilot study on learning, memory, and safety. Pharmacol Biochem Behav 51:509-514
46. Wonnacott S, Irons J, Rapier C, Thorne B, Lunt GG (1989) Presynaptic modulation of transmitter release by nicotinic receptors. In : Nordberg A, Fuxe K, Holmstedt B, Sundwall A (eds) Progress in brain research. Elsevier, New York, pp 157-163